Intellectual Property
Probiodrug has established an in-house patent department, which meets the industry standard.
The company owns a broad international patent portfolio protecting its proprietary technologies and targets in the major pharmaceutical markets. The continuously expanding patent portfolio covers the chemical space as well as the medical use of effectors of the company’s proprietary targets, pathways, proprietary pharmacological test systems and assays.
Status information on Probiodrug’s published patent applications can be retrieved from customary databases.